← Back to Search

Osteopathic Manipulative Therapy for Respiratory Diseases

N/A
Waitlist Available
Led By Margaret Moore, DO
Research Sponsored by Geisinger Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients age of 65-100
Be older than 65 years old
Must not have
Patients with active or previously diagnosed liver disease
Patients that have a healing fracture, including the spine, pelvis, shoulder, ribs, vertebrae, or extremities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion of up to one year.
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate whether Osteopathic Manipulative Therapy (OMT) can help patients with respiratory illnesses and their symptoms. The study will see if adding OMT to standard care can reduce symptoms

Who is the study for?
This trial is for patients recently diagnosed with respiratory illnesses like bronchitis, sinus infections, and pneumonia. It's open to those who are receiving standard care for these conditions but have not yet tried Osteopathic Manipulative Therapy (OMT).
What is being tested?
The study tests if adding OMT to usual care improves recovery in respiratory illness patients. The goal is to see if symptoms resolve faster and the overall sickness duration decreases compared to standard treatment alone.
What are the potential side effects?
OMT is a manual therapy so potential side effects may include discomfort during or after treatment, minor bruising, headache, or fatigue. However, it's generally considered safe with minimal risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 65 and 100 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have or had liver disease.
Select...
I am currently healing from a bone fracture.
Select...
I am currently undergoing cancer treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion of up to one year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion of up to one year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To address the magnitude in which lymphatic pump OMT improves respiratory illness symptom severity and overall sickness duration when combined with standard care treatment.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
Patients will receive lymphatic pump OMT therapy in addition to other standard care (similar to the control patients, this would be a medication, follow-up instructions, etc.)
Group II: ControlActive Control1 Intervention
Patients in the control group will receive normal standard care, including any prescriptions, follow-up instructions, etc., as given by the provider to help treat their condition.

Find a Location

Who is running the clinical trial?

Geisinger ClinicLead Sponsor
154 Previous Clinical Trials
1,978,618 Total Patients Enrolled
1 Trials studying Pneumonia
100 Patients Enrolled for Pneumonia
Margaret Moore, DOPrincipal InvestigatorPhysician
~45 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top